Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 12:20 PM
Ignite Modification Date:
2025-12-25 @ 12:03 PM
NCT ID:
NCT05552261
Group ID:
EG000
Title:
Group Long-term Follow-up - FAS
Description:
All eligible patients in the original NGF0120 study, after completing enrollment, were invited to enter the Long-Term Follow-up Study (NGF0122) (all standard of care permitted), according to inclusion and exclusion criteria.
The NGF0122 study aim was to assess the safety and efficacy of OXERVATE® 0.002% (20 mcg/mL) cenegermin-bkbj ophtalmic solution administered in Stage 1 Neurotrophic Keratitis patients enrolled in the original NGF0120 study.
No intervention was performed in this extension study.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
1
Serious Number At Risk:
24
Other Number Affected:
20
Other Number At Risk:
24
Study:
NCT05552261
Results Section:
NCT05552261
Adverse Events Module:
NCT05552261